mdlinx mdlinx

Oncology News Articles

The latest Cancer and Oncology news articles. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the medical articles that will make a difference to you and your practice. Organized by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants can stay current on latest Cancer/Oncology clinical articles.

Hematology exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. Featured are clinical pearls from The Smartest Oncologist to oncology topics from the Smartest Doc daily quiz challenge.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Oncology!

Articles

Latest (109) Full Text Articles (6313) Focus on Urology
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

1 Minimising critical organ irradiation in limited stage Hodgkin lymphoma: A dosimetric study of the benefit of involved node radiotherapy Full Text Annals of Oncology, October 8, 2012 Original Publication Date: October 7, 2011    Clinical Article

2 Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma Full Text Annals of Oncology, October 8, 2012 Original Publication Date: October 7, 2011

3 Multicenter, Phase II Study of Axitinib, a Selective Second-Generation Inhibitor of Vascular Endothelial Growth Factor Receptors 1, 2, 3, in Patients with Metastatic Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 10, 2011    Clinical Article

4 A Phase I Dose Esclation Study of Tivantinib in Adult Pts w Metastatic Solid Tumors Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 10, 2011    Clinical Article

5 Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258)-an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors-in Patients with Advanced Melanoma Full Text Clinical Cancer Research, October 8, 2012 Original Publication Date: October 10, 2011    Clinical Article

6 Repeated and Aggressive Pulmonary Resections for Leiomyosarcoma Metastases Extends Survival Full Text Annals of Thoracic Surgery, October 8, 2012 Original Publication Date: October 10, 2011

7 HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS Full Text Blood, October 8, 2012 Original Publication Date: October 10, 2011

8 Pam50 breast cancer subtyping by RT-QPCR and concordance with standard clinical molecular markers Full Text BMC Genomics, October 8, 2012

9 Breast vibro-acoustography: initial results show promise Full Text Breast Cancer Research, October 8, 2012

10 Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes Full Text Breast Cancer Research, October 8, 2012

11 Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines Full Text BMC Cancer, October 8, 2012

12 Falls in nursing home residents receiving pharmacotherapy for anemia Full Text Clinical Interventions in Aging, October 8, 2012

13 Phase I and pharmacokinetic study of pazopanib and lapatinib combination therapy in patients with advanced solid tumors Full Text Investigational New Drugs, October 8, 2012    Clinical Article

14 Body mass index, abdominal fatness and pancreatic cancer risk: A systematic review and non-linear doseresponse meta-analysis of prospective studies Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 6, 2011    Clinical Article

15 Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 7, 2011    Evidence Based Medicine    Clinical Article

16 Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 7, 2011    Clinical Article

17 The Effect of a Multidisciplinary Thoracic Malignancy Conference on the Treatment of Patients With Esophageal Cancer Full Text Annals of Thoracic Surgery, October 7, 2012 Original Publication Date: October 7, 2011

18 Pulmonary Resection for Metastatic Adrenocortical Carcinoma: The National Cancer Institute Experience Full Text Annals of Thoracic Surgery, October 7, 2012 Original Publication Date: October 7, 2011

19 The "Rib-Like" Technique for Surgical Treatment of Sternal Tumors: Lessons Learned From 101 Consecutive Cases Full Text Annals of Thoracic Surgery, October 7, 2012 Original Publication Date: October 7, 2011

20 Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy Full Text Annals of Oncology, October 7, 2012 Original Publication Date: October 7, 2011

316 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Clinical Pearls in Oncology

Highlights in Oncology

VEGFR-1 is a prognostic marker for HCC

As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.

Read the article summary

HCC risk increased in patients with AIDS

As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.

Read the article summary

RAB25 is a prognostic marker for ovarian cancer

As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top Articles of 2013

1 Coffee intake and gastric cancer risk Cancer Epidemiology, Biomarkers & Prevention, March 20, 2014

2 Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial The Lancet Oncology, March 7, 2014

3 Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial The Lancet Oncology, March 11, 2014

4 Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials The Lancet, March 25, 2014    Evidence Based Medicine

5 Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): A companion analysis of a randomised controlled trial The Lancet Oncology, March 14, 2014

6 Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: A meta-analysis of randomized trials Oncology, February 4, 2014    Evidence Based Medicine

7 Risk of developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation Journal of the National Cancer Institute, March 4, 2014

8 Screening for prostate cancer with the prostate-specific antigen test: A review of current evidence JAMA, March 21, 2014    Evidence Based Medicine

9 Dietary carrot consumption and the risk of prostate cancer European Journal of Nutrition, February 17, 2014

10 Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: A meta-analysis of individual patient data The Lancet Oncology, March 7, 2014

11 A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients Annals of Oncology, February 18, 2014

12 Radical prostatectomy or watchful waiting in early prostate cancer New England Journal of Medicine, March 10, 2014    Evidence Based Medicine

13 Coffee consumption and prostate cancer risk: An updated meta-analysis Cancer Causes and Control, March 4, 2014    Evidence Based Medicine

14 Statins and aspirin for chemoprevention in Barrett's esophagus: Results of a cost-effectiveness analysis Cancer Prevention Research, February 25, 2014

15 Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): Follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort The Lancet Oncology, March 24, 2014

16 Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab Journal of Clinical Oncology, March 19, 2014

17 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 13, 2014    Evidence Based Medicine

18 Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study The Lancet Oncology, March 3, 2014

19 Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial Journal of Clinical Oncology, February 3, 2014

20 Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial Annals of Oncology, March 12, 2014

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close